---
figid: PMC3165445__zek9990937530001
figlink: /pmc/articles/PMC3165445/figure/F1/
number: F1
caption: Summary of the modes of action of selected small molecules that modulate
  morphogenesis in Candida albicans. (A) Several small molecules, including farnesol
  (FOH), conjugated linoleic acid (CLA), rapamycin (Rapa), geldanamycin (GdA), mucin,
  diclofenac sodium, 1,4-diamino-2-butanone (DAB), hydroxyurea (HU), propranolol,
  and bathophenanthrolene disulfonic acid (BPS), modulate morphogenesis by targeting
  the Ras1p-cAMP-PKA signaling pathway and its downstream effectors. Notably, both
  CLA and GdA modulate morphogenesis independently of Efg1p. Extended CRIB (eCRIB)
  peptides interrupt the binding of the GTPase Cdc42p to its effectors Cst20p and
  Cla4p, and thus prevent the activation of the MAP kinase (MAPK) pathway. (B) Farnesol
  and CLA block the downregulation of TUP1 and NRG1 expression. In contrast, rapamycin
  induces the downregulation of both repressors by inhibiting TOR. (C) Trichostatin
  A (TSA) induces filamentation by relieving the Set3C-mediated repression of Efg1p-dependent
  transcription. TSA may also reduce EFG1 transcript levels (see text for details).
  HSGs, hypha-specific genes.
pmcid: PMC3165445
papertitle: Modulation of Morphogenesis in Candida albicans by Various Small Molecules
  .
reftext: Julie Shareck, et al. Eukaryot Cell. 2011 Aug;10(8):1004-1012.
pmc_ranked_result_index: '122251'
pathway_score: 0.8140982
filename: zek9990937530001.jpg
figtitle: Summary of the modes of action of selected small molecules that modulate
  morphogenesis in Candida albicans
year: '2011'
organisms:
- Homo sapiens
ndex: bb63feed-df28-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3165445__zek9990937530001.html
  '@type': Dataset
  description: Summary of the modes of action of selected small molecules that modulate
    morphogenesis in Candida albicans. (A) Several small molecules, including farnesol
    (FOH), conjugated linoleic acid (CLA), rapamycin (Rapa), geldanamycin (GdA), mucin,
    diclofenac sodium, 1,4-diamino-2-butanone (DAB), hydroxyurea (HU), propranolol,
    and bathophenanthrolene disulfonic acid (BPS), modulate morphogenesis by targeting
    the Ras1p-cAMP-PKA signaling pathway and its downstream effectors. Notably, both
    CLA and GdA modulate morphogenesis independently of Efg1p. Extended CRIB (eCRIB)
    peptides interrupt the binding of the GTPase Cdc42p to its effectors Cst20p and
    Cla4p, and thus prevent the activation of the MAP kinase (MAPK) pathway. (B) Farnesol
    and CLA block the downregulation of TUP1 and NRG1 expression. In contrast, rapamycin
    induces the downregulation of both repressors by inhibiting TOR. (C) Trichostatin
    A (TSA) induces filamentation by relieving the Set3C-mediated repression of Efg1p-dependent
    transcription. TSA may also reduce EFG1 transcript levels (see text for details).
    HSGs, hypha-specific genes.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MAPK14
  - UBQLN3
  - MAPK3
  - MAPK13
  - PRKAR2A
  - PRKAR2B
  - MAPK10
  - PRKACA
  - MAPK9
  - MAPK12
  - NRG1
  - GDA
  - RORC
  - PRKACB
  - MAPK8
  - PRDX2
  - MAPK1
  - PRKAR1B
  - TRERF1
  - MAPK11
  - PRKACG
  - PRKAR1A
  - diclofenac sodium
  - propranolol
genes:
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: NRG1,TUP1
  symbol: TUP-1
  source: hgnc_alias_symbol
  hgnc_symbol: UBQLN3
  entrez: '50613'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR2A
  entrez: '5576'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR2B
  entrez: '5577'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKACA
  entrez: '5566'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: NRG1,
  symbol: NRG1
  source: hgnc_symbol
  hgnc_symbol: NRG1
  entrez: '3084'
- word: GdA
  symbol: GDA
  source: hgnc_symbol
  hgnc_symbol: GDA
  entrez: '9615'
- word: TOR
  symbol: TOR
  source: hgnc_alias_symbol
  hgnc_symbol: RORC
  entrez: '6097'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKACB
  entrez: '5567'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: TSA
  symbol: TSA
  source: hgnc_alias_symbol
  hgnc_symbol: PRDX2
  entrez: '7001'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR1B
  entrez: '5575'
- word: Rapa
  symbol: RAPA
  source: hgnc_alias_symbol
  hgnc_symbol: TRERF1
  entrez: '55809'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKACG
  entrez: '5568'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR1A
  entrez: '5573'
chemicals:
- word: diclofenac sodium
  source: MESH
  identifier: D004008
- word: propranolol
  source: MESH
  identifier: D011433
diseases: []
figid_alias: PMC3165445__F1
redirect_from: /figures/PMC3165445__F1
figtype: Figure
---
